Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Have you been diagnosed with COPD ?

Purpose

We are currently participating in a study to assess the efficacy and safety of different doses of study medication in patients with moderate to severe chronic obstructive pulmonary disease, using an active control.

Patient Inclusion Criteria:

  • Diagnosed with COPD
  • Current or past smoker
  • Age 40 or older
  • A history of smoking a pack a day for 10 plus years

Patient Exclusion Criteria:

  • Diagnosed with asthma
  • Use oxygen for more than 15 hours a day
  • Diagnosed with cancer or a history of cancer
Participants will receive study-related care and medications at no cost. Compensation may be available for time and travel

To Learn more
Phase

3

Gender

Both Male and Female

Age

40 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Sherena doctor, Study Coordinator
Central Medical Group, P.A Research
6610 N. University Drive
Suite 120
Tamarac, FL 33321
Phone: 954-720-7211
Fax: 954-720-6119

View Map

Research Center Information: Central Medical Group, P.A Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180206

Date Last Changed: July 19, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.